Those populations most vulnerable to cannabis-related adverse health events stand to benefit from a regulatory environment that promotes consumer education, product quality control and responsible use. The post NORML Op-Ed: Legalizing Marijuana Does Not Jeopardize Mental Health appeared first on NORML.

“States’ real-world experience with marijuana legalization proves that these policies can be implemented in a manner that provides regulated access for adults while simultaneously limiting youth access and misuse.” The post Study: Far Fewer High-Schoolers Are Consuming Cannabis appeared first on NORML.

“Many older adults struggle with pain, anxiety, restless sleep, and other conditions for which cannabis products often mitigate. Many older adults are also well aware of the litany of serious adverse side-effects associated with available prescription drugs, like opioids or sleep aids, and they perceive medical cannabis to be a practical and potentially safer alternative.”     The post

Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now. The post NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling appeared first on NORML.